^
Association details:
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Source:
Title:

HER2 G776S mutation promotes oncogenic potential in colorectal cancer cells when accompanied by loss of APC function

Published date:
06/02/2022
Excerpt:
...afatinib, a pan-HER tyrosine kinase inhibitor, suppressed tumor growth in xenografts derived from HER2 G776S-transfected CRC cells.
DOI:
10.1038/s41598-022-13189-y